These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

212 related items for PubMed ID: 14745072

  • 1. The impact of pregnancy and childbirth on the metabolism of lamotrigine.
    Pennell PB, Newport DJ, Stowe ZN, Helmers SL, Montgomery JQ, Henry TR.
    Neurology; 2004 Jan 27; 62(2):292-5. PubMed ID: 14745072
    [Abstract] [Full Text] [Related]

  • 2. Lamotrigine in pregnancy: pharmacokinetics during delivery, in the neonate, and during lactation.
    Ohman I, Vitols S, Tomson T.
    Epilepsia; 2000 Jun 27; 41(6):709-13. PubMed ID: 10840403
    [Abstract] [Full Text] [Related]

  • 3. Lamotrigine clearance during pregnancy.
    Tran TA, Leppik IE, Blesi K, Sathanandan ST, Remmel R.
    Neurology; 2002 Jul 23; 59(2):251-5. PubMed ID: 12136066
    [Abstract] [Full Text] [Related]

  • 4. Gestation-induced changes in lamotrigine pharmacokinetics: a monotherapy study.
    de Haan GJ, Edelbroek P, Segers J, Engelsman M, Lindhout D, Dévilé-Notschaele M, Augustijn P.
    Neurology; 2004 Aug 10; 63(3):571-3. PubMed ID: 15304599
    [Abstract] [Full Text] [Related]

  • 5. Plasma concentrations of lamotrigine and its 2-N-glucuronide metabolite during pregnancy in women with epilepsy.
    Ohman I, Beck O, Vitols S, Tomson T.
    Epilepsia; 2008 Jun 10; 49(6):1075-80. PubMed ID: 18076642
    [Abstract] [Full Text] [Related]

  • 6. Lamotrigine in pregnancy and lactation: a case report.
    Tomson T, Ohman I, Vitols S.
    Epilepsia; 1997 Sep 10; 38(9):1039-41. PubMed ID: 9579945
    [Abstract] [Full Text] [Related]

  • 7. Antiepileptic drug pharmacokinetics during pregnancy and lactation.
    Pennell PB.
    Neurology; 2003 Sep 01; 61(6 Suppl 2):S35-42. PubMed ID: 14504308
    [Abstract] [Full Text] [Related]

  • 8. Lamotrigine in pregnancy: clearance, therapeutic drug monitoring, and seizure frequency.
    Pennell PB, Peng L, Newport DJ, Ritchie JC, Koganti A, Holley DK, Newman M, Stowe ZN.
    Neurology; 2008 May 27; 70(22 Pt 2):2130-6. PubMed ID: 18046009
    [Abstract] [Full Text] [Related]

  • 9. Prospectively assessed changes in lamotrigine-concentration in women with epilepsy during pregnancy, lactation and the neonatal period.
    Fotopoulou C, Kretz R, Bauer S, Schefold JC, Schmitz B, Dudenhausen JW, Henrich W.
    Epilepsy Res; 2009 Jul 27; 85(1):60-4. PubMed ID: 19272754
    [Abstract] [Full Text] [Related]

  • 10. Seizure frequency in pregnant women treated with lamotrigine monotherapy.
    Sabers A, Petrenaite V.
    Epilepsia; 2009 Sep 27; 50(9):2163-6. PubMed ID: 19490048
    [Abstract] [Full Text] [Related]

  • 11. Valproate effects on kinetics of lamotrigine in pregnancy and treatment with oral contraceptives.
    Tomson T, Luef G, Sabers A, Pittschieler S, Ohman I.
    Neurology; 2006 Oct 10; 67(7):1297-9. PubMed ID: 17030773
    [Abstract] [Full Text] [Related]

  • 12. Lamotrigine clearance increases by 5 weeks gestational age: Relationship to estradiol concentrations and gestational age.
    Karanam A, Pennell PB, French JA, Harden CL, Allien S, Lau C, Barnard S, Callisto SP, Birnbaum AK.
    Ann Neurol; 2018 Oct 10; 84(4):556-563. PubMed ID: 30168175
    [Abstract] [Full Text] [Related]

  • 13. Lamotrigine kinetics within the menstrual cycle, after menopause, and with oral contraceptives.
    Wegner I, Edelbroek PM, Bulk S, Lindhout D.
    Neurology; 2009 Oct 27; 73(17):1388-93. PubMed ID: 19858461
    [Abstract] [Full Text] [Related]

  • 14. The effects of co-medications on lamotrigine clearance in Japanese children with epilepsy.
    Takeuchi T, Natsume J, Kidokoro H, Ishihara N, Yamamoto H, Azuma Y, Ito Y, Kurahashi N, Tsuji T, Suzuki M, Itomi K, Yamada K, Kurahashi H, Abe S, Okumura A, Maruyama K, Negoro T, Watanabe K, Kojima S.
    Brain Dev; 2016 Sep 27; 38(8):723-30. PubMed ID: 27033151
    [Abstract] [Full Text] [Related]

  • 15. Effect of comedication on lamotrigine clearance in Korean epilepsy patients.
    Kim HJ, Kim TE, Joo EY, Seo DW, Lee SY, Hong SB.
    Clin Chim Acta; 2015 Jan 01; 438():269-73. PubMed ID: 25218785
    [Abstract] [Full Text] [Related]

  • 16. Saliva and serum concentration of lamotrigine in patients with epilepsy.
    Tsiropoulos I, Kristensen O, Klitgaard NA.
    Ther Drug Monit; 2000 Oct 01; 22(5):517-21. PubMed ID: 11034255
    [Abstract] [Full Text] [Related]

  • 17. Sodium valproate acutely inhibits lamotrigine metabolism.
    Yuen AW, Land G, Weatherley BC, Peck AW.
    Br J Clin Pharmacol; 1992 May 01; 33(5):511-3. PubMed ID: 1524964
    [Abstract] [Full Text] [Related]

  • 18. The relationship between UGT1A4 polymorphism and serum concentration of lamotrigine in patients with epilepsy.
    Gulcebi MI, Ozkaynakcı A, Goren MZ, Aker RG, Ozkara C, Onat FY.
    Epilepsy Res; 2011 Jun 01; 95(1-2):1-8. PubMed ID: 21601426
    [Abstract] [Full Text] [Related]

  • 19. Estrogen profile- and pharmacogenetics-based lamotrigine dosing regimen optimization: Recommendations for pregnant women with epilepsy.
    Wang ML, Tao YY, Sun XY, Guo Y, Wang ZY, Cao YF, Zhao L.
    Pharmacol Res; 2021 Jul 01; 169():105610. PubMed ID: 33857625
    [Abstract] [Full Text] [Related]

  • 20. Drug monitoring of lamotrigine and oxcarbazepine combination during pregnancy.
    Wegner I, Edelbroek P, de Haan GJ, Lindhout D, Sander JW.
    Epilepsia; 2010 Dec 01; 51(12):2500-2. PubMed ID: 21204816
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.